fbpx Skip to main content

BioCommunique Article

Additional testing options from members Biocept, Enable Biosciences, Helix, StemExpress, and Verily Life Sciences listed in Biocom’s Testing Solutions addendum.

Biocom Announces First Endorsed Testing Solution in Partnership with One Medical

  • 2020-07-23T19:00:00.000+0000
  • California
  • Author: Harry Chang

As California’s life science industry continues to ease back into workspaces, labs and research facilities, COVID-19 testing remains a keystone piece of any return to work strategy.

On Monday, Biocom released a Testing Solutions addendum to connect members with turnkey solutions for securing best-in-class testing. The Testing Solutions accompany the Task Force’s Return to Work Guide: The Path Forward, both of which can be found on Biocom’s Return to Work page.

Biocom also announced its first endorsed smart testing solution with One Medical, which provides members of all sizes with access to the national, membership-based primary care practice at a significantly discounted membership rate. One Medical’s workplace reentry program, Healthy Together, is based on the latest CDC guidelines and scientific evidence and protects both physical and mental health.

While widespread testing has been cost-prohibitive until now, especially for smaller life science companies, Biocom’s testing solutions connect members with One Medical’s entire suite of convenient offices across the U.S., and 24/7 virtual care from their app. The program is accessible through a 90-day trial period at an over 50% discount from standard Per Employee Per Month rates.

To learn more information about the 90-day trial and request a quote, click here.

Also featured in the Testing Solutions addendum are several Biocom members offering additional reliable COVID-19 testing, including Biocept, Enable Biosciences, Helix, StemExpress, and Verily Life Sciences. All testing options have been analyzed with an easy-to-use matrix to help life science companies compare each and select the best option for their team.

By signing up for a 90-day discount trial, members can expect to receive access to daily COVID-19 screening to determine employee risk levels; access to testing if assessments recommend an employee should be tested; access to easy reporting tools, 24/7 help, and mental health resources; and, a playbook with One Medical’s best practices for workplace reentry and safety recommendations.

Researching, working, and innovating safely together will be a collaborative effort on all fronts for our entire industry. Biocom and Biocom's Return to Work task force are confident that our Testing Solutions and Return to Work resources will provide valuable tools to help California’s already collaborative life science industry lead the way in returning to work together in as safe a manner as possible.

To learn more and/or enroll download Biocom’s Testing Solutions addendum.